Detalhe da pesquisa
1.
A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts.
Malar J
; 22(1): 364, 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031175
2.
Repeated mosquito net distributions, improved treatment, and trends in malaria cases in sentinel health facilities in Papua New Guinea.
Malar J
; 18(1): 364, 2019 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718659
3.
Insecticide-treated nets and malaria prevalence, Papua New Guinea, 2008-2014.
Bull World Health Organ
; 95(10): 695-705B, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29147042
4.
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
PLoS Med
; 12(10): e1001891, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26505753
5.
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Antimicrob Agents Chemother
; 59(7): 4260-71, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25963981
6.
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
PLoS Med
; 11(12): e1001773, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25549086
7.
The association of intraleucocytic malaria pigment and disease severity in Papua New Guinean children with severe P. falciparum malaria.
Trans R Soc Trop Med Hyg
; 117(11): 797-803, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334767
8.
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
Int J Infect Dis
; 130: 189-195, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906121
9.
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
PLoS Negl Trop Dis
; 16(2): e0010096, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139070
10.
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Lancet Infect Dis
; 22(8): 1200-1209, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533701
11.
Investigating differences in village-level heterogeneity of malaria infection and household risk factors in Papua New Guinea.
Sci Rep
; 11(1): 16540, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34400687
12.
Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
PLoS Negl Trop Dis
; 11(7): e0005753, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732068
13.
Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria.
Acta Trop
; 160: 1-8, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27056132
14.
Insecticide-treated nets and malaria prevalence, Papua New Guinea, 2008–2014
Bull. W.H.O. (Print)
; 95(10): 695-705B, 2017-10-01.
Artigo
em Inglês
| WHOLIS | ID: who-272178